Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




AI May Improve Diagnostic Interpretation of Lung Function Tests

By LabMedica International staff writers
Posted on 12 Sep 2016
A first study in the field of lung testing suggests that diagnosis of long-term lung diseases could be improved using artificial intelligence (AI) algorithms developed to interpret results compiled from currently used tests.

The study, presented September 4 at the European Respiratory Society's International Congress (London, UK, September 3-7, 2016), is the first to explore the potential use of AI for improving accuracy of diagnosis of lung diseases. More...
Current testing requires a series of assays including a spirometry test (measures the volume amount and the flow speed of air during breathing), followed by a body plethysmography test (measures static lung volumes and airways resistance), then finally a diffusion test (measures amount of oxygen and other gases that cross the lungs' air sacs). Analysis of the results of these tests is largely based on expert opinion and international guidelines, attempting to detect patterns.

The new study included data from 968 people who were undergoing complete lung function testing for the first time. All participants received a first clinical diagnosis based on lung function tests and additional tests (e.g. CT scans, electrocardiogram, etc.). Final diagnosis was validated by a consensus of the large group of expert clinicians.

The researchers subsequently investigated whether “machine learning” (utilizing algorithms that can learn from data analysis and perform predictions) could be used to effectively analyze a complete set of lung function tests. They developed an algorithm process in addition to the routine lung function parameters and clinical variables of smoking history, body mass index, and age. Based on the pattern of both the clinical and lung function data, the algorithm provided a suggestion for the most likely diagnosis.

Wim Janssens from University of Leuven (Leuven, Belgium), study senior author, said: "We have demonstrated that AI can provide us with a more accurate diagnosis in this new study. The beauty of our development is that the algorithm can simulate the complex reasoning that a clinician uses to give their diagnosis, but in a more standardized and objective way."

Clinicians currently rely on analyzing the results using population-based parameters. With AI, the machine can observe a combination of patterns simultaneously to help produce a more accurate diagnosis. This has been done in other healthcare fields, such as with an automated interpretation of results from an electrocardiogram being routinely used in clinical practice as a decision support system.

Marko Topalovic, University of Leuven, study first author, said: "The benefit of this method is a more accurate and automated interpretation of pulmonary function tests, and thus better disease detection. Not only can this help non-experienced clinicians, but it also has many benefits for healthcare overall as it is time saving in achieving a final diagnosis as it could decrease the number of redundant additional tests clinicians are taking to confirm the diagnosis."

The next step will be to test the algorithm in different populations and increase the system’s decision power using continuous updates on lung function data with validated clinical diagnoses.

Related Links:
University of Leuven


New
Gold Member
Automatic CLIA Analyzer
Shine i9000
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Research has linked platelet aggregation in midlife blood samples to early brain markers of Alzheimer’s (Photo courtesy of Shutterstock)

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.